AliveCor, AstraZeneca bring non-invasive potassium monitoring solutions
AliveCor, AstraZeneca bring non-invasive potassium monitoring solutions AliveCor, AstraZeneca bring non-invasive potassium monitoring solutions 17 February 2021 | News Source credit: Shutterstock AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, has announced a new collaboration with AstraZeneca, a global science-led biopharmaceutical company, to research new disease management solutions in cardiovascular, renal, and metabolism (CVRM) the...
Aman Bhatti Breakthrough Device Designation Biopharma Partnerships R Amp D Metabolism Therapeutic Areas Potassium Detection
Source: biospectrumindia.com